Clinical Trial Update: Efficacy and Safety of Sorafenib (Nexavar) in Combination With Gemcitabine in Advanced Hepatocellular Carcinoma (HCC) [Phase 2]

View source ↗

Summary

This Phase 2 trial assesses the efficacy and safety of combining sorafenib with gemcitabine in advanced hepatocellular carcinoma and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Gemzar (gemcitabine)
• Nexavar (Sorafenib)

Snippet

Sponsor: Mahidol University | Conditions: Carcinoma, Hepatocellular | Phase 2 | Status: COMPLETED